 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pacer Advisors Inc. increased its stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD  Free Report) by 9.0% during the second quarter, according to the company in its most recent 13F filing...

Pacer Advisors Inc. Buys 204,428 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

This is a Bullish indicator signaling IRWD's price could rise from here. Traders may explore going long the stock or buying call options...

Ironwood Pharmaceuticals (IRWD, $8.61) Moving Average Convergence Divergence (MACD) Histogram turned positive on September 18, 2023

Unraveling the Factors That Could Limit Ironwood Pharmaceuticals Inc's OutperformanceRelated Stocks: IRWD...

Ironwood Pharmaceuticals Inc (IRWD): A Deep Dive into Its Performance Potential

Is the stock modestly undervalued? Let's delve into the details.Related Stocks: IRWD...

Ironwood Pharmaceuticals (IRWD): A Comprehensive Analysis of Its Market Value

Brandywine Global Investment Management LLC purchased a new position in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD  Free Report) during the 1st quarter, according to the company in...

254,051 Shares in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Purchased by Brandywine Global Investment Management LLC

This is a signal that IRWD's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Ironwood Pharmaceuticals (IRWD, $8.66) RSI Indicator left the oversold zone on September 12, 2023

This price move could be a signal that IRWD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options...

Ironwood Pharmaceuticals (IRWD, $8.25) price may climb as it broke lower Bollinger Band on Sep 08, 2023

Ironwood Pharmaceuticals (IRWD, $8.25) RSI Indicator left the oversold zone on September 08, 2023

California State Teachers Retirement System trimmed its holdings in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD Free Report) by 1.3% during the 1st quarter, Holdings Channel reports. The institutional investor owned 172,135 shares of the biotechnology companys stock after selling 2,335 ...

California State Teachers Retirement System Sells 2,335 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Guggenheim Capital LLC lessened its stake in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD  Free Report) by 9.4% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 319,383 shares of the ...

Guggenheim Capital LLC Sells 33,056 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.

Watchers	1,849
52-Wk Low	$8.08
52-Wk High	$12.66

Market Cap	$1.47B
Volume (M)	1.47M
52-Wk High	$12.66
52-Wk Low	$8.08

IRWD Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

About

Feed

News

Sentiment

Earnings

Fundamentals